Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 1:47 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
MORGAN STANLEY MS |
3,099,198 6.400% |
3,099,198 (New Position) |
Filing History |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
ARK Investment Management LLC | 3,194,999 6.590% |
3,194,999 (New Position) |
Filing History |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
BlackRock Inc. BLK |
4,643,736 9.600% |
501,208 (+12.10%) |
Filing History |
| 2024-01-23 10:28 am Sale |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
STATE STREET CORP STT |
921,322 1.900% |
-1,586,665 (-63.26%) |
Filing History |
| 2023-02-24 4:13 pm Purchase |
2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,717,171 5.750% |
450,602 (+19.88%) |
Filing History |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 4,899,772 9.900% |
1,941,488 (+65.63%) |
Filing History |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 184,544 0.400% |
-2,366,213 (-92.77%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 4,801,954 9.990% |
2,347,872 (+95.67%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
T. Rowe Price Associates, Inc. | 3,253,736 6.900% |
-1,617,348 (-33.20%) |
Filing History |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,266,569 4.810% |
-169,595 (-6.96%) |
Filing History |
| 2023-02-10 10:54 am Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
STATE STREET CORP STT |
2,507,987 5.320% |
2,507,987 (New Position) |
Filing History |
| 2023-02-08 1:07 pm Purchase |
2023-02-08 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS LP | 2,538,632 5.400% |
2,538,632 (New Position) |
Filing History |
| 2023-01-25 10:36 am Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
BlackRock Inc. BLK |
4,142,528 8.800% |
1,594,667 (+62.59%) |
Filing History |
| 2022-06-10 4:02 pm Purchase |
2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,436,164 5.190% |
2,436,164 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 2,958,284 6.600% |
112,159 (+3.94%) |
Filing History |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 2,550,757 5.700% |
-2,871,792 (-52.96%) |
Filing History |
| 2022-02-14 4:15 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 2,454,082 5.500% |
2,454,082 (New Position) |
Filing History |
| 2022-02-14 2:35 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
T. Rowe Price Associates, Inc. | 4,871,084 10.900% |
244,189 (+5.28%) |
Filing History |
| 2022-02-11 4:34 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
COLUMN GROUP L P | 654,245 1.500% |
-6,101,636 (-90.32%) |
Filing History |
| 2022-02-11 3:11 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Foresite Capital Fund IV, L.P. | 1,205,798 2.700% |
-2,045,051 (-62.91%) |
Filing History |